[Viferon efficacy in influenza in adult patients].

The therapeutic efficacy of Viferon (suppositories of human recombinant interferon alfa-2) was investigated in a double-blind controlled study with the use of Arbidol as a reference drug in the treatment of patients with influenza. Viferon and Arbidol lowered the signs of the fever, intoxication, catarrh and the disease as the whole.
AuthorsA N Vasil'ev, R Z Gatich, L V Kolobukhina, E I Isaeva, E I Burtseva, T G Orlova, F V Voronina, V V Malinovskaia
JournalAntibiotiki i khimioterapii︠a︡ = Antibiotics and chemoterapy [sic] / Ministerstvo meditsinskoĭ i mikrobiologicheskoĭ promyshlennosti SSSR (Antibiot Khimioter) Vol. 54 Issue 3-4 Pg. 21-5 ( 2009) ISSN: 0235-2990 [Print] Russia (Federation)
PMID19711845 (Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antiviral Agents
  • Indoles
  • Interferon-alpha
  • Recombinant Proteins
  • Suppositories
  • interferon alfa-2a
  • arbidol
  • Adolescent
  • Adult
  • Antiviral Agents (adverse effects, therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Indoles (adverse effects, therapeutic use)
  • Influenza, Human (drug therapy)
  • Interferon-alpha (adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Recombinant Proteins
  • Suppositories
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: